Key Details
Price
$4.55Annual ROE
-135.25%Beta
1.15Events Calendar
Next earnings date:
May 14, 2025Recent quarterly earnings:
May 14, 2024Recent annual earnings:
Mar 31, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 15, 2024Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with QNTM included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Quantum BioPharma doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
QNTM
accesswire.com21 October 2024
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders TORONTO, ON / ACCESSWIRE / October 21, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces the Company, on 20th October 2024, has filed a complaint in the United States District Court for the Southern District of New York alleging that CIBC World Markets (CIBC), RBC Dominion Securities (RBC), and others (the "Defendants") engaged in market manipulation schemes that violated Section 10(b) and Rule 10b-5(a) and (c) and Section 9(a) of the Securities Exchange Act of 1934.
FAQ
- What is the primary business of Quantum BioPharma?
- What is the ticker symbol for Quantum BioPharma?
- Does Quantum BioPharma pay dividends?
- What sector is Quantum BioPharma in?
- What industry is Quantum BioPharma in?
- What country is Quantum BioPharma based in?
- Is Quantum BioPharma in the S&P 500?
- Is Quantum BioPharma in the NASDAQ 100?
- Is Quantum BioPharma in the Dow Jones?
- When was Quantum BioPharma's last earnings report?
- When does Quantum BioPharma report earnings?
- Should I buy Quantum BioPharma stock now?
What is the primary business of Quantum BioPharma?
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
What is the ticker symbol for Quantum BioPharma?
The ticker symbol for Quantum BioPharma is NASDAQ:QNTM
Does Quantum BioPharma pay dividends?
No, Quantum BioPharma does not pay dividends
What sector is Quantum BioPharma in?
Quantum BioPharma is in the Healthcare sector
What industry is Quantum BioPharma in?
Quantum BioPharma is in the Drug Manufacturers - Specialty & Generic industry
What country is Quantum BioPharma based in?
Quantum BioPharma is headquartered in Canada
Is Quantum BioPharma in the S&P 500?
No, Quantum BioPharma is not included in the S&P 500 index
Is Quantum BioPharma in the NASDAQ 100?
No, Quantum BioPharma is not included in the NASDAQ 100 index
Is Quantum BioPharma in the Dow Jones?
No, Quantum BioPharma is not included in the Dow Jones index
When was Quantum BioPharma's last earnings report?
Quantum BioPharma's most recent earnings report was on 14 May 2024
When does Quantum BioPharma report earnings?
The next expected earnings date for Quantum BioPharma is 14 May 2025
Should I buy Quantum BioPharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions